Alvotech Kicks Off Trials For Eylea Biosimilar

AVT06 Proposed Version Of Aflibercept Enters Clinical Studies

 
• By Dave Wallace

Alvotech has announced the start of clinical trials for its AVT06 proposed aflibercept biosimilar rival to Eylea, joining a host of other developers pursuing the same target.

Eye data binary
Trials are beginning for Alvotech’s aflibercept biosimilar • Source: Shutterstock

More from Biosimilars

More from Products